Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
27 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-27/abcellera-doses-first-participants-in-a-phase-1-clinical-trial-of-abcl575
12 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250812333835/en/AbCellera-to-Participate-at-Upcoming-Investor-Conferences-in-September
07 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250807114104/en/AbCellera-Reports-Q2-2025-Business-Results-First-Participants-Dosed-in-a-Phase-1-Clinical-Trial-of-ABCL635-for-Vasomotor-Symptoms
07 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250707945378/en/AbCellera-to-Report-Second-Quarter-2025-Financial-Results-on-August-7-2025
30 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250530123396/en/AbCellera-Receives-Authorization-from-Health-Canada-to-Initiate-a-Phase-1-Clinical-Trial-of-ABCL575
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516112255/en/AbCellera-Receives-Authorization-from-Health-Canada-to-Initiate-the-Phase-1-Clinical-Trial-of-ABCL635-for-Vasomotor-Symptoms-Due-to-Menopause
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE